FDA approves new melanoma drug from Bristol-Myers

December 23, 2014 4:18 AM

15 0

WASHINGTON (AP) – The Food and Drug Administration granted accelerated approval Monday to a new drug from Bristol-Myers Squibb to treat the deadliest form of skin cancer.

The agency approved Opdivo for patients with hard-to-treat melanoma that cannot be removed via surgery or has spread throughout the body. The approval was based on preliminary results showing the drug helped shrink tumors in some patients.

Read more

To category page